PUBLICATION

Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression

Authors
Effendi, K., Yamazaki, K., Mori, T., Masugi, Y., Makino, S., and Sakamoto, M.
ID
ZDB-PUB-121010-35
Date
2013
Source
Experimental cell research   319(1): 35-44 (Journal)
Registered Authors
Makino, Shinji
Keywords
skeletal muscle, actin, cancer, development, HCC cells, zebrafish
MeSH Terms
  • Disease Progression
  • Phenotype
  • Liver Neoplasms/embryology
  • Liver Neoplasms/metabolism*
  • Liver Neoplasms/pathology
  • Zebrafish/embryology*
  • Zebrafish/genetics*
  • Animals
  • Membrane Proteins/genetics
  • Membrane Proteins/metabolism*
  • Zebrafish Proteins/chemistry
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/physiology*
  • Biomarkers, Tumor/genetics
  • Biomarkers, Tumor/metabolism*
  • Gene Expression Regulation, Developmental/physiology
  • Gene Knockdown Techniques
  • Molecular Sequence Data
  • Male
  • Gene Expression Regulation, Neoplastic/physiology
  • Carcinoma, Hepatocellular/metabolism*
  • Carcinoma, Hepatocellular/pathology
  • Carcinoma, Hepatocellular/secondary
  • Female
  • Humans
  • Amino Acid Sequence
  • Cell Line, Tumor
  • Adaptor Proteins, Signal Transducing/chemistry
  • Adaptor Proteins, Signal Transducing/genetics
  • Adaptor Proteins, Signal Transducing/metabolism*
  • Adaptor Proteins, Signal Transducing/physiology*
(all 31)
PubMed
23022774 Full text @ Exp. Cell Res.
Abstract

Cyclase-associated protein 2 (CAP2) is a conserved protein that is found up-regulated in hepatocellular carcinoma (HCC). By using zebrafish, combined with HCC cell lines, we further investigated the role of CAP2. The zebrafish CAP2 sequence was 60% identical to human CAP2 with 77% homology in the C-terminal actin-binding domain, and 58% in the N-terminal cyclase-binding domain. CAP2 expression was observed during zebrafish development and was preferentially expressed in the skeletal muscle and heart. Knockdown using two different morpholinos against CAP2 resulted in a short-body morphant zebrafish phenotype with pericardial edema. CAP2 was observed co-localized with actin in zebrafish skeletal muscle, and in the leading edge of lamellipodium in HCC cell lines. CAP2 silencing resulted in a defect in lamellipodium formation and decreased cell motility in HCC cell lines. Strongly positive expression of CAP2 was observed in 10 of 16 (63%) poorly, 30 of 68 (44%) moderately, and 2 of 21 (10%) well differentiated HCC. CAP2 expression was significantly associated with tumor size, poor differentiation, portal vein invasion, and intrahepatic metastasis. Our results indicate that an important conserved function of CAP2 in higher vertebrates may be associated with the process of skeletal muscle development. CAP2 also played an important role in enhancing cell motility, which may promote a more invasive behavior in the progression of HCC. These findings highlight the link between development and cancer.

Genes / Markers
Figures
No images available
Show all Figures
Expression
Phenotype
Mutations / Transgenics
No data available
Human Disease / Model
No data available
Sequence Targeting Reagents
Target Reagent Reagent Type
cap1MO1-cap1MRPHLNO
cap2MO1-cap2MRPHLNO
cap2MO2-cap2MRPHLNO
1 - 3 of 3
Show
Fish
Antibodies
Orthology
Engineered Foreign Genes
No data available
Mapping